Vapotherm Performance
| VAPODelisted Stock | USD 0.40 0.00 0.00% |
The entity has a beta of 1.18, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Vapotherm will likely underperform. Vapotherm right now has a risk of 0.0%. Please validate Vapotherm treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Vapotherm will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Vapotherm has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Vapotherm is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 57.3 M | |
| Total Cashflows From Investing Activities | -11.6 M |
Vapotherm |
Vapotherm Relative Risk vs. Return Landscape
If you would invest 40.00 in Vapotherm on August 30, 2024 and sell it today you would earn a total of 0.00 from holding Vapotherm or generate 0.0% return on investment over 90 days. Vapotherm is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of otc stocks are less volatile than Vapotherm, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Vapotherm Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vapotherm's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Vapotherm, and traders can use it to determine the average amount a Vapotherm's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| VAPO |
Based on monthly moving average Vapotherm is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vapotherm by adding Vapotherm to a well-diversified portfolio.
Vapotherm Fundamentals Growth
Vapotherm OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Vapotherm, and Vapotherm fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Vapotherm OTC Stock performance.
| Return On Equity | -6.87 | |||
| Return On Asset | -0.31 | |||
| Profit Margin | (1.03) % | |||
| Operating Margin | (0.63) % | |||
| Current Valuation | 102.76 M | |||
| Shares Outstanding | 6.14 M | |||
| Price To Book | 7.11 X | |||
| Price To Sales | 0.11 X | |||
| Revenue | 66.8 M | |||
| EBITDA | (72.13 M) | |||
| Cash And Equivalents | 49.88 M | |||
| Cash Per Share | 1.87 X | |||
| Total Debt | 99.31 M | |||
| Debt To Equity | 7.19 % | |||
| Book Value Per Share | (7.74) X | |||
| Cash Flow From Operations | (80.16 M) | |||
| Earnings Per Share | (14.33) X | |||
| Total Asset | 96.19 M | |||
| Retained Earnings | (490 M) | |||
| Current Asset | 2.57 M | |||
| Current Liabilities | 739 K | |||
About Vapotherm Performance
By examining Vapotherm's fundamental ratios, stakeholders can obtain critical insights into Vapotherm's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Vapotherm is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire. Vapotherm operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 510 people.Things to note about Vapotherm performance evaluation
Checking the ongoing alerts about Vapotherm for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Vapotherm help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Vapotherm is not yet fully synchronised with the market data | |
| Vapotherm has some characteristics of a very speculative penny stock | |
| Vapotherm has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 66.8 M. Net Loss for the year was (113.26 M) with profit before overhead, payroll, taxes, and interest of 18.19 M. | |
| Vapotherm currently holds about 49.88 M in cash with (80.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 17.0% of the company outstanding shares are owned by insiders |
- Analyzing Vapotherm's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vapotherm's stock is overvalued or undervalued compared to its peers.
- Examining Vapotherm's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vapotherm's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vapotherm's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Vapotherm's otc stock. These opinions can provide insight into Vapotherm's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Vapotherm OTC Stock
If you are still planning to invest in Vapotherm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vapotherm's history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |